Minerva Neurosciences (NERV) Shares Outstanding (Weighted Average) (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Shares Outstanding (Weighted Average) data on file, last reported at $43.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 480.0% year-over-year to $43.9 million; the trailing twelve-month figure through Mar 2026 stood at $43.9 million (up 480.0% YoY), and the FY2025 full-year result was $8.5 million, up 11.82% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $43.9 million, up from $8.5 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $43.9 million in Q1 2026 and bottomed at $5.3 million in Q1 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $7.6 million (2024), against an average of $8.8 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) sank 87.5%; it then jumped 480.0% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $5.3 million in 2022, then increased by 21.84% to $6.5 million in 2023, then rose by 16.33% to $7.6 million in 2024, then grew by 11.82% to $8.5 million in 2025, then jumped by 418.7% to $43.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $43.9 million (Q1 2026), $8.5 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison